404 related articles for article (PubMed ID: 24805070)
1. Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function.
Sarter M; Albin RL; Kucinski A; Lustig C
Exp Neurol; 2014 Jul; 257():120-9. PubMed ID: 24805070
[TBL] [Abstract][Full Text] [Related]
2. Make a Left Turn: Cortico-Striatal Circuitry Mediating the Attentional Control of Complex Movements.
Sarter M; Avila C; Kucinski A; Donovan E
Mov Disord; 2021 Mar; 36(3):535-546. PubMed ID: 33615556
[TBL] [Abstract][Full Text] [Related]
3. Complex Movement Control in a Rat Model of Parkinsonian Falls: Bidirectional Control by Striatal Cholinergic Interneurons.
Avila C; Kucinski A; Sarter M
J Neurosci; 2020 Jul; 40(31):6049-6067. PubMed ID: 32554512
[TBL] [Abstract][Full Text] [Related]
4. Modeling falls in Parkinson's disease: Slow gait, freezing episodes and falls in rats with extensive striatal dopamine loss.
Kucinski A; Albin RL; Lustig C; Sarter M
Behav Brain Res; 2015 Apr; 282():155-64. PubMed ID: 25595423
[TBL] [Abstract][Full Text] [Related]
5. Modeling fall propensity in Parkinson's disease: deficits in the attentional control of complex movements in rats with cortical-cholinergic and striatal-dopaminergic deafferentation.
Kucinski A; Paolone G; Bradshaw M; Albin RL; Sarter M
J Neurosci; 2013 Oct; 33(42):16522-39. PubMed ID: 24133257
[TBL] [Abstract][Full Text] [Related]
6. Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson's disease.
Gilat M; Bell PT; Ehgoetz Martens KA; Georgiades MJ; Hall JM; Walton CC; Lewis SJG; Shine JM
Neuroimage; 2017 May; 152():207-220. PubMed ID: 28263926
[TBL] [Abstract][Full Text] [Related]
7. Reducing falls in Parkinson's disease: interactions between donepezil and the 5-HT
Kucinski A; de Jong IE; Sarter M
Eur J Neurosci; 2017 Jan; 45(2):217-231. PubMed ID: 27469080
[TBL] [Abstract][Full Text] [Related]
8. Reduction of falls in a rat model of PD falls by the M1 PAM TAK-071.
Kucinski A; Sarter M
Psychopharmacology (Berl); 2021 Jul; 238(7):1953-1964. PubMed ID: 33735392
[TBL] [Abstract][Full Text] [Related]
9. Modeling Parkinson's disease falls associated with brainstem cholinergic systems decline.
Kucinski A; Sarter M
Behav Neurosci; 2015 Apr; 129(2):96-104. PubMed ID: 25798629
[TBL] [Abstract][Full Text] [Related]
10. History of falls in Parkinson disease is associated with reduced cholinergic activity.
Bohnen NI; Müller ML; Koeppe RA; Studenski SA; Kilbourn MA; Frey KA; Albin RL
Neurology; 2009 Nov; 73(20):1670-6. PubMed ID: 19917989
[TBL] [Abstract][Full Text] [Related]
11. Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson's disease.
Koshy Cherian A; Kucinski A; Wu R; de Jong IEM; Sarter M
Psychopharmacology (Berl); 2019 Jun; 236(6):1701-1715. PubMed ID: 30607479
[TBL] [Abstract][Full Text] [Related]
12. The interplay of cholinergic function, attention, and falls in Parkinson's disease.
Yarnall A; Rochester L; Burn DJ
Mov Disord; 2011 Dec; 26(14):2496-503. PubMed ID: 21898597
[TBL] [Abstract][Full Text] [Related]
13. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.
Christopher L; Marras C; Duff-Canning S; Koshimori Y; Chen R; Boileau I; Segura B; Monchi O; Lang AE; Rusjan P; Houle S; Strafella AP
Brain; 2014 Feb; 137(Pt 2):565-75. PubMed ID: 24334314
[TBL] [Abstract][Full Text] [Related]
14. Overview of the cholinergic contribution to gait, balance and falls in Parkinson's disease.
Morris R; Martini DN; Madhyastha T; Kelly VE; Grabowski TJ; Nutt J; Horak F
Parkinsonism Relat Disord; 2019 Jun; 63():20-30. PubMed ID: 30796007
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic systems, attentional-motor integration, and cognitive control in Parkinson's disease.
Albin RL; van der Zee S; van Laar T; Sarter M; Lustig C; Muller MLTM; Bohnen NI
Prog Brain Res; 2022; 269(1):345-371. PubMed ID: 35248201
[TBL] [Abstract][Full Text] [Related]
16. D1 dopamine receptor agonist-induced Fos-like immunoreactivity occurs in basal forebrain and mesopontine tegmentum cholinergic neurons and striatal neurons immunoreactive for neuropeptide Y.
Robertson GS; Staines WA
Neuroscience; 1994 Mar; 59(2):375-87. PubMed ID: 7911982
[TBL] [Abstract][Full Text] [Related]
17. Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson's disease.
Ztaou S; Amalric M
Neurochem Int; 2019 Jun; 126():1-10. PubMed ID: 30825602
[TBL] [Abstract][Full Text] [Related]
18. Nicotinic acetylcholine receptors interact with dopamine in induction of striatal long-term depression.
Partridge JG; Apparsundaram S; Gerhardt GA; Ronesi J; Lovinger DM
J Neurosci; 2002 Apr; 22(7):2541-9. PubMed ID: 11923419
[TBL] [Abstract][Full Text] [Related]
19. The cortical cholinergic system contributes to the top-down control of distraction: Evidence from patients with Parkinson's disease.
Kim K; Müller MLTM; Bohnen NI; Sarter M; Lustig C
Neuroimage; 2019 Apr; 190():107-117. PubMed ID: 29277400
[TBL] [Abstract][Full Text] [Related]
20. Key role of striatal cholinergic interneurons in processes leading to arrest of motor stereotypies.
Aliane V; Pérez S; Bohren Y; Deniau JM; Kemel ML
Brain; 2011 Jan; 134(Pt 1):110-8. PubMed ID: 21097493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
